Downregulation of MYC or MYCN protein expression upon MYCMI-7 treatment was also confirmed in HeLa, P493-6, HCT116 cells, and in MYCN-amplified Kelly neuroblastoma cells (Supplementary Fig. S2A–D). The gene discussed is MYCN; the disease is neuroblastoma.